In support, we find that reduction of select iDL signaling in CD4+ or CD8+ T cells mitigates an inflammatory landscape, reduces insulitis and preserves β-cell mass resulting in a delay in T1D onset and an overall decrease in T1D incidence. This evidence concerns the gene CD4 and type 1 diabetes mellitus.